Acta Pharmaceutica Sinica B 2019 Impact Factor 7.097

导出

摘要 Acta Pharmaceutica Sinica B(APSB)has been selected for coverage in the Science Citation Index Expanded(SCIE),online at the Web of Knowledge.Coverage of this title in SCIE begins with Vol.5 No.1,2015.The 2019 Impact Factor was released as 7.097,ranking 13/270 in the category Pharmacology and Pharmacy.

出处《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第1期308-308,共1页 药学学报（英文版）

关键词 PHARMACY IMPACT CATEGORY

分类号 R-5 [医药卫生] G23 [文化科学]

引文网络
相关文献

1Acta Pharmaceutica Sinica B 2019 Impact Factor 7.097[J].Acta Pharmaceutica Sinica B,2020,10(11):2008-2008.
2Huigen Yang.Editorial Note[J].Advances in Polar Science,2021,32(1).
3Qiwen Yang,Xiaoling Ma,Fupin Hu,Jing Zhang,Tongwen Sun,Baiyi Chen,Yingchun Xu,Youning Liu,Chinese Committee on Antimicrobial Susceptibility Testing(ChiCAST),Expert Committee on Infectious Diseases,China Medical Education Association.Expert Consensus on Polymyxin Antimicrobial Susceptibility Testing and Clinical Interpretation[J].Chinese Medical Sciences Journal,2021,36(1):1-16. 被引量：1
4Guidelines for Submissions to China & World Economy[J].China & World Economy,2021,29(2).

Acta Pharmaceutica Sinica B

2021年第1期

浏览历史

内容加载中请稍等...

Acta Pharmaceutica Sinica B 2019 Impact Factor 7.097

相关作者

相关机构

相关主题

浏览历史